Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Axsome Thera (NQ: AXSM )

98.22 +0.03 (+0.03%)
Streaming Delayed Price Updated: 11:51 AM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Axsome Thera

< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $... 
Via Benzinga
Why Is Axsome Therapeutics (AXSM) Stock Up Today?
Axsome Therapeutics (AXSM) stock is on the rise Tuesday as the company edges closer to its first drug approval from the FDA. 
Via InvestorPlace
Axsome Therapeutics Stock Rockets As Its First FDA Approval Looks Imminent
The company agreed to the FDA's post-marketing requirements for a depression drug. 
Via Investor's Business Daily
Axsome Therapeutics Stock Is Surging: Here's Why
Axsome Therapeutics Inc (NASDAQ: AXSM) shares are trading higher Tuesday after the company announced it received and agreed to Postmarketing Requirements/Commitments proposed... 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More
Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates
Biopharma stocks are sensitive to a key binary event called the PDUFA date, the date by which the Food and Drug Administration is required to give its verdict on a regulatory application filed with... 
Via Benzinga
Peering Into Axsome Therapeutics Inc's Recent Short Interest
Axsome Therapeutics Inc's (NASDAQ:AXSM) short percent of float has risen 15.16% since its last report. The company recently reported that it has 4.42 million shares sold short,... 
Via Benzinga
Why Axsome Therapeutics Stock Is Trading Higher
Axsome Therapeutics Inc (NASDAQ: AXSM) is trading higher Monday morning after the company announced it will acquire Sunosi from Jazz Therapeutics PLC (NASDAQ: JAZZ). 
Via Benzinga
Axsome Acquires Sleep Disorder Drug From Jazz Pharma, Expanding Its Neuroscience Portfolio
Axsome Therapeutics Inc (NASDAQ: AXSM) has  
Via Benzinga
Best Biotech Stocks To Buy In 2022
Biotechnology is the study of living creatures, biological systems, or derivatives to develop or improve healthcare products and therapies. This technology is connected with medical and... 
Via Talk Markets
Axsome Therapeutics: Q4 Earnings Insights
Axsome Therapeutics (NASDAQ:AXSM) reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Agile Therapeutics (NASDAQ:AGRX) ... 
Via Benzinga
Stock Wars: Axsome Therapeutics Vs. Global Blood Therapeutics
Benzinga’s weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment. 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers ContraFect (NASDAQ:CFRX) stock mo... 
Via Benzinga
2 Top Biotech Stocks Ready for a Bull Run
Both of these companies have potential catalysts on the way. 
Via The Motley Fool
Axsome Therapeutics, inc (AXSM) Q3 2021 Earnings Call Transcript
AXSM earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Why Axsome Therapeutics Stock Is Rising Today
The company provided its third-quarter update. 
Via The Motley Fool
2 Biotech Stocks Poised for Jaw-Dropping Growth
These two tiny drugmakers could make early shareholders wealthy. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Why Axsome Therapeutics Stock Rocketed Higher This Week
Optimism among investors is growing for the possible approval of the biotech's MDD drug. 
Via The Motley Fool
1 Beaten-Down Stock With 10X Potential
This biotech is down, but it isn't out just yet. 
Via The Motley Fool
45 Biggest Movers From Yesterday
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on... 
Via Benzinga
Why Axsome Therapeutics Stock Caught Fire in September
This beaten-down biotech regained some lost ground last month. 
Via The Motley Fool
Axsome Therapeutics, Inc. (NASDAQ:AXSM) Shareholder Notice: Investigation over Possible Wrongdoing
San Diego, CA -- (SBWIRE) -- 09/29/2021 -- An investigation was announced over potential breaches of fiduciary duties by certain officers and directors at Axsome Therapeutics, Inc. 
Via SBWire
Exposures Product Safety
Why Wall Street Thinks This Biotech Stock Can Triple Your Money
The risks are huge, but so are the potential returns. 
Via The Motley Fool
Why Axsome Therapeutics Stock Cratered in August
An unexpected regulatory setback weighed heavily on the biotech's shares last month. 
Via The Motley Fool
The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 15) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE... 
Via Benzinga
Exposures COVID-19
< Previous 1 2
...
13 14 15 16 17 18 19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.